Increased Expression of Myeloid-Derived Suppressor Cells in Patients with HBV-Related Hepatocellular Carcinoma

Table 1

Relationships between the frequency of MDSCs and clinical characteristics of HCC patients.

Characteristics		MDSCs (%)
Gender
Male	37		0.439
Female	11
Age
≤50	19		0.337
>50	29
Tumor size
≤5 cm	22		0.934
>5 cm	26
Tumor number
Single	13		0.776
Multiple	35
Tumor metastasis
No	22		0.852
Yes	26
BCLC stage
0/A/B	22		0.852
C/D	26
Liver cirrhosis
Compensation	14		0.295
Decompensation	34
Child-Pugh
A	16		0.353
B/C	32
Ascites
No	11		0.786
Yes	37
HBeAg
+	34		0.298
-	14
HBV-DNA
≤2000 copies/mL	35		0.410
>2000 copies/mL	13
AFP
≤400 ng/mL	26		0.260
>400 ng/mL	22